(1)
Evaluation of Cellular, Acellular, and Matrix-Like Products (CAMPs) in the Management of Nonhealing Diabetic Foot Ulcers: An Interim Analysis of the STABLECAMP Trial. ijtr 2025, 1 (Suppl 2). https://doi.org/10.63676/yt45kp42.